Companies 0 See All

Hedge Funds 0 See All

Insiders 0 See All

Institutional Investors 0 See All

Click here to see all results for

Home > Insider Trading > Filing (0001209191-22-046598)

Filing Details

Accession Number:: 0001209191-22-046598
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2022-08-18 16:07:27
Reporting Period:: 2022-08-16

Accepted Time:: 2022-08-18 16:07:27
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1740279	In8Bio Inc.	INAB	()	4

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1434099	C. Peter Brandt	C/O In8Bio, Inc. 350 5Th Ave. Suite 5330 New York NY 10118		Yes	No	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Acquisiton	2022-08-16	105,263	$1.90	182,473	No	4	P	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	P	Direct

Reported Non-Derivative Holdings

Sec. Name	Remaning Holdings	Nature of Ownership	Explanation
Common Stock	105,290	Indirect	See footnote

Footnotes

Includes 77,210 shares received as an annual annuity payment from the Reporting Person's GRAT. This transfer constitutes a mere change in the form of ownership and is exempt from reporting pursuant to Rule 16a-13.
The securities are held by The Peter C. Brandt 2020-4 GRAT (the "GRAT"). The Reporting Person is the trustee of the GRAT and, as such, has voting and investment power over the shares held by the GRAT.